Aliskiren and Renin Inhibition in Diastolic Heart Failure

NCT00773084 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Difficulty in recruiting patients and then the PI left the institution

Conditions

Diastolic Heart Failure

Interventions

DRUG: Aliskiren plus spironolactone vs. Lisinopril plus spironolactone

Sponsor

Texas Tech University Health Sciences Center